LABP
Landos Biopharma, Inc. Common Stock
LABP
LABP
Delisted
LABP was delisted on the 23rd of May, 2024.
35 hedge funds and large institutions have $331M invested in Landos Biopharma, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 15 reducing their positions, and 3 closing their positions.
Holders
35
Holders Change
+2
Holders Change %
+6.06%
% of All Funds
0.61%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
10
Reduced
15
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
O
1
OrbiMed
New York
|
$4.14M |
2 |
![]()
2
JPMorgan Chase & Co
New York
|
$4.53M |
3 |
3
BlackRock
New York
|
$3.41M |
4 |
4
Northern Trust
Chicago,
Illinois
|
$682K |
5 |
5
Geode Capital Management
Boston,
Massachusetts
|
$1.65M |